Capability At The Core: Why Workforce Expansion Is Central To India’s Pharma Growth - Shivani Jain

India’s pharmaceutical industry is entering a defining phase of expansion that is reshaping how the sector operates, supported by stronger domestic capabilities, deeper scientific focus, wider therapy coverage, and greater integration of technology across the value chain, manufacturing systems, and even quality check systems. As treatment approaches evolve and modernise, companies are scaling not only in size but also in operational depth and execution discipline, transforming the very core of the pharmaceutical sector. To adapt to this phenomenon, organisations require specialized and technical competency in terms of skill development at all levels, influencing how pharmaceutical companies plan and expand their workforce. Understanding these forces offers clarity on factors currently driving growth within the pharmaceutical sector in India.

Manufacturing Depth and Self-Reliance

The push for greater self-reliance in the pharmaceutical sector is creating a significant impact on manufacturing strategy in India. India’s pharma industry is poised to achieve $450 billion by 2047 while focussing on innovations and growth in global markets. Companies, thereby, are strengthening manufacturing ecosystems and investing in capacity building, reflecting India’s growing role in global supply chains. Such expansion plans require skilled and trained professionals, directly impacting capability development and long-term workforce planning across the organisation.

Technology Integration Across Operations

There is also a growing emphasis on digital adoption in the pharmaceutical industry. Digital technologies such as automation of production processes, data analytics of quality processes, AI-based research tools, and digital engagement platforms of business processes have become the norm. Gone are the days when technology was seen as a supporting function.

This integration has given rise to a demand for professionals with a dual expertise in the pharmaceutical industry and in possessing skills related to the digital domain. Data analysis, process optimization/validation, and regulatory technology are some of the skill sets considered increasingly relevant in the industry. As per reports, quality focus, digital integration, and skilled talent are seen by a majority of sector leaders, as critical enablers of long-term growth. Workforce planning is therefore closely linked to technology strategy.

Government Programs and Expanding Access

Public health initiatives aimed at expanding healthcare access are also influencing pharmaceutical demand, with a focus on improving access to the right treatment. Additionally, the recent Union Budget announcement of the Biopharma Shakti initiative, along with other critical investments, is an important strategy, which is helpful in improving the capabilities of the Indian market to innovate, strengthening our research and development capabilities, and more closely aligning India to the global drug development and manufacturing capabilities. As pharmaceutical operations grow, companies are increasing production, strengthening distribution networks, and bringing more structure to field activities. Every stage of this expansion requires people who understand their roles clearly and can work within defined quality and compliance standards.

Evolving Skill Requirements

Traditional roles in manufacturing, quality, and sales continue to grow. As per reports, in the pharma industry, skilled workforce is deemed to be one of the key enablers by over 80% of pharma experts to achieve the vision of Viksit Bharat. There has, however, been a shift in the qualifications that are needed for traditional manufacturing, quality, and sales roles, with an increased need for regulatory affairs, medical science liaison, data analysis, pharmacovigilance, digital operations management, and many other roles. This change has made factors like upskilling initiatives and industry-academia collaboration essential, as regulatory standards evolve and technologies advance. Companies are investing in structured training programs to ensure that workforce capability keeps pace with scientific and operational progress.

The Road Ahead

India’s pharmaceutical industry is not simply expanding, it is maturing. The conversations today are no longer limited to volumes or market share. They are about capability, and long-term contribution to public health. Workforce expansion, in this sense, reflects confidence in the sector’s direction. As technology evolves and the requirements of the pharmaceutical industry become more complex and nuanced, investing in human capital and being able to attract people who can think in a critical and responsible manner and adapt well to change, is the key to continued growth and success. The future of Indian pharma will not be defined only by the scale it achieves, but by the depth of expertise it builds. If the sector continues to strengthen its talent foundation alongside infrastructure and innovation, it will be well positioned to deliver growth that is not only substantial, but sustainable and meaningful.

The above information is the author's own; Outlook India is not involved in the creation of this article.